DIA421.18-2.67 -0.63%
SPX5,890.28-31.26 -0.53%
IXIC19,117.22-81.95 -0.43%

Company News for May 14, 2025

Barchart·05/14/2025 09:44:17
Listen to the news
  • Shares of Under Armour, Inc. (UAA) gained 1% after the company reported fourth-quarter fiscal 2025 loss of $0.08 per share, narrower than the Zacks Consensus Estimate of a loss of $0.09 per share. 
  • Landstar System, Inc.’s (LSTR) shares declined 2.5% after the company reported first-quarter 2025 earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.92 per share. 
  • Shares of Silicon Laboratories Inc. (SLAB) jumped 5.7% after the company reported first-quarter 2025 loss of $0.08 per share, narrower than the Zacks Consensus Estimate of a loss of $0.09 per share.
  • CG Oncology, Inc.’s (CGON) shares declined 3.9% after the company reported first-quarter 2025 loss of $0.45 per share, broader than the Zacks Consensus Estimate of a loss of $0.39 per share. 

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Silicon Laboratories, Inc. (SLAB): Free Stock Analysis Report
 
Landstar System, Inc. (LSTR): Free Stock Analysis Report
 
Under Armour, Inc. (UAA): Free Stock Analysis Report
 
CG Oncology, Inc. (CGON): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.